Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors - Université de Rennes Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2016

Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors

Christine Vala
  • Fonction : Auteur
  • PersonId : 777556
  • IdRef : 134530268
Pascal Bonnet
Olivier Lozach
Gérald Guillaumet
  • Fonction : Auteur
  • PersonId : 964449
  • IdRef : 060700777

Résumé

An efficient synthetic strategy able to modulate the structure of the tetrahydropyridine isoindolone (Valmerin) skeleton was developed. A library of more than 30 novel final structures was generated. Biological activities on CDK5 and GSK3 as well as cellular effects on cancer cell lines were measured for each novel compound. Additionally to support the SAR, a docking study was performed. A potent GSK3/CDK5 dual inhibitor (37, IC50 CDK5/GSK3 35/7 nM) was obtained. Best antiproliferative effects were obtained on lung and prostate cell lines with IC50 = 20 nM
Fichier non déposé

Dates et versions

hal-01295635 , version 1 (31-03-2016)

Identifiants

Citer

Aziz Ouach, Rajâa Boulahjar, Christine Vala, Stéphane Bourg, Pascal Bonnet, et al.. Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors. European Journal of Medicinal Chemistry, 2016, 115, pp.311--325. ⟨10.1016/j.ejmech.2016.02.072⟩. ⟨hal-01295635⟩
244 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More